Home dialysis device gets safety check in ongoing study

NCT ID NCT04198012

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study allowed 25 people with end-stage kidney disease to keep using the HemoCare hemodialysis system at home while the device was being reviewed for market approval. The main goal was to track safety events like side effects or device problems. Participants needed a trained care partner to help with treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
HemoCare™ Hemodialysis System (a device for home hemodialysis)
What this could lead to
If successful, this could help make home hemodialysis more accessible for people with kidney failure, offering more flexibility and convenience.
What could go wrong
This is a small, completed study focused on continued access and safety monitoring, not a test of new benefits. The device still requires a trained care partner and may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • DCI North Brunswick

    North Brunswick, New Jersey, 08902, United States

  • Dialysis Clinic, Inc.

    Knoxville, Tennessee, 37920, United States

  • Dialysis Clinic, Inc.

    Nashville, Tennessee, 37203, United States

  • The Rogosin Institute

    New York, New York, 11021, United States

  • University of Mississippi Medical Center

    Jackson, Mississippi, 39213, United States

  • Wellbound North Austin

    Austin, Texas, 78758, United States

  • Wellbound South Austin

    Austin, Texas, 78744, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.